Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
19.15 USD | -2.10% | +5.45% | +5.74% |
04-26 | EU Panel Backs Approval of Takeda’s Colorectal Cancer Drug | MT |
04-26 | Hutchmed notes CHMP's positive opinion for fruiquintinib approval | AN |
Sales 2024 * | 681M 932M | Sales 2025 * | 836M 1.14B | Capitalization | 3.32B 4.54B |
---|---|---|---|---|---|
Net income 2024 * | -109M -149M | Net income 2025 * | -5M -6.84M | EV / Sales 2024 * | 4.58 x |
Net cash position 2024 * | 199M 272M | Net cash position 2025 * | 306M 418M | EV / Sales 2025 * | 3.61 x |
P/E ratio 2024 * |
-28.7
x | P/E ratio 2025 * |
604
x | Employees | 1,988 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 52.37% |
Latest transcript on HUTCHMED (China) Limited
1 day | -2.10% | ||
1 week | +5.45% | ||
Current month | +3.46% | ||
1 month | +13.52% | ||
3 months | +54.94% | ||
6 months | -2.79% | ||
Current year | +5.74% |
Managers | Title | Age | Since |
---|---|---|---|
Wei Guo Su
CEO | Chief Executive Officer | 66 | 04-12-31 |
Chig Fung Cheng
DFI | Director of Finance/CFO | 57 | 08-06-30 |
Michael Shi
CTO | Chief Tech/Sci/R&D Officer | 59 | 21-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chi Keung To
CHM | Chairman | 72 | 99-12-31 |
Graeme Jack
BRD | Director/Board Member | 73 | 17-02-28 |
Dan Eldar
BRD | Director/Board Member | 70 | 16-07-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.77% | 4 M€ | -27.92% | ||
0.76% | 96 M€ | -.--% | - | |
0.00% | 7 M€ | +3.48% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-03 | 19.15 | -2.10% | 155,159 |
24-05-02 | 19.56 | +4.26% | 120,034 |
24-05-01 | 18.76 | +1.35% | 30,266 |
24-04-30 | 18.51 | -2.12% | 54,130 |
24-04-29 | 18.91 | +4.13% | 267,609 |
Delayed Quote Nasdaq, May 03, 2024 at 04:30 pm
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+21.85% | 546B | |
-4.77% | 359B | |
+16.97% | 323B | |
+5.69% | 290B | |
+13.68% | 234B | |
+3.65% | 198B | |
-11.12% | 194B | |
+8.08% | 167B | |
-3.40% | 157B |
- Stock Market
- Equities
- HCM Stock
- HCM Stock